184 related articles for article (PubMed ID: 20926893)
1. Ccm1 regulates microvascular morphogenesis during angiogenesis.
Liu H; Rigamonti D; Badr A; Zhang J
J Vasc Res; 2011; 48(2):130-40. PubMed ID: 20926893
[TBL] [Abstract][Full Text] [Related]
2. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish.
Hogan BM; Bussmann J; Wolburg H; Schulte-Merker S
Hum Mol Genet; 2008 Aug; 17(16):2424-32. PubMed ID: 18469344
[TBL] [Abstract][Full Text] [Related]
3. Ccm3 functions in a manner distinct from Ccm1 and Ccm2 in a zebrafish model of CCM vascular disease.
Yoruk B; Gillers BS; Chi NC; Scott IC
Dev Biol; 2012 Feb; 362(2):121-31. PubMed ID: 22182521
[TBL] [Abstract][Full Text] [Related]
4. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
Wüstehube J; Bartol A; Liebler SS; Brütsch R; Zhu Y; Felbor U; Sure U; Augustin HG; Fischer A
Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12640-5. PubMed ID: 20616044
[TBL] [Abstract][Full Text] [Related]
5. Ccm1 assures microvascular integrity during angiogenesis.
Liu H; Rigamonti D; Badr A; Zhang J
Transl Stroke Res; 2010 Jun; 1(2):146-53. PubMed ID: 21562623
[TBL] [Abstract][Full Text] [Related]
6. Lack of CCM1 induces hypersprouting and impairs response to flow.
Mleynek TM; Chan AC; Redd M; Gibson CC; Davis CT; Shi DS; Chen T; Carter KL; Ling J; Blanco R; Gerhardt H; Whitehead K; Li DY
Hum Mol Genet; 2014 Dec; 23(23):6223-34. PubMed ID: 24990152
[TBL] [Abstract][Full Text] [Related]
7. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.
Zheng X; Xu C; Di Lorenzo A; Kleaveland B; Zou Z; Seiler C; Chen M; Cheng L; Xiao J; He J; Pack MA; Sessa WC; Kahn ML
J Clin Invest; 2010 Aug; 120(8):2795-804. PubMed ID: 20592472
[TBL] [Abstract][Full Text] [Related]
8. Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.
Zhu Y; Wu Q; Xu JF; Miller D; Sandalcioglu IE; Zhang JM; Sure U
Neurosurg Focus; 2010 Sep; 29(3):E1. PubMed ID: 20809750
[TBL] [Abstract][Full Text] [Related]
9. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations.
Cuttano R; Rudini N; Bravi L; Corada M; Giampietro C; Papa E; Morini MF; Maddaluno L; Baeyens N; Adams RH; Jain MK; Owens GK; Schwartz M; Lampugnani MG; Dejana E
EMBO Mol Med; 2016 Jan; 8(1):6-24. PubMed ID: 26612856
[TBL] [Abstract][Full Text] [Related]
10. Vertebrate Models to Investigate CCM Pathogenesis: The Zebrafish and Mouse Model.
Abou-Fadel J; Zhang J
Methods Mol Biol; 2020; 2152():225-251. PubMed ID: 32524556
[TBL] [Abstract][Full Text] [Related]
11. Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
Li W; Tran V; Shaked I; Xue B; Moore T; Lightle R; Kleinfeld D; Awad IA; Ginsberg MH
Elife; 2021 May; 10():. PubMed ID: 34013885
[TBL] [Abstract][Full Text] [Related]
12. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
[TBL] [Abstract][Full Text] [Related]
13. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations.
Whitehead KJ; Plummer NW; Adams JA; Marchuk DA; Li DY
Development; 2004 Mar; 131(6):1437-48. PubMed ID: 14993192
[TBL] [Abstract][Full Text] [Related]
14. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
Pagenstecher A; Stahl S; Sure U; Felbor U
Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
[TBL] [Abstract][Full Text] [Related]
15. Study of CCM Microvascular Endothelial Phenotype by an In Vitro Tubule Differentiation Model.
Delle Monache S; Retta SF
Methods Mol Biol; 2020; 2152():371-375. PubMed ID: 32524565
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype.
Borikova AL; Dibble CF; Sciaky N; Welch CM; Abell AN; Bencharit S; Johnson GL
J Biol Chem; 2010 Apr; 285(16):11760-4. PubMed ID: 20181950
[TBL] [Abstract][Full Text] [Related]
17. CCM1 regulates vascular-lumen organization by inducing endothelial polarity.
Lampugnani MG; Orsenigo F; Rudini N; Maddaluno L; Boulday G; Chapon F; Dejana E
J Cell Sci; 2010 Apr; 123(Pt 7):1073-80. PubMed ID: 20332120
[TBL] [Abstract][Full Text] [Related]
18. From Genes and Mechanisms to Molecular-Targeted Therapies: The Long Climb to the Cure of Cerebral Cavernous Malformation (CCM) Disease.
Retta SF; Perrelli A; Trabalzini L; Finetti F
Methods Mol Biol; 2020; 2152():3-25. PubMed ID: 32524540
[TBL] [Abstract][Full Text] [Related]
19. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
Stockton RA; Shenkar R; Awad IA; Ginsberg MH
J Exp Med; 2010 Apr; 207(4):881-96. PubMed ID: 20308363
[TBL] [Abstract][Full Text] [Related]
20. Generation of CCM Phenotype by a Human Microvascular Endothelial Model.
Delle Monache S; Retta SF
Methods Mol Biol; 2020; 2152():131-137. PubMed ID: 32524549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
